Found 6 matching trials
Traditional Versus Early Aggressive Therapy for Multiple Sclerosis Trial
NAFDA-approved multiple sclerosis (MS) disease-modifying therapies (DMTs) tar...
Status
Active Not Recruiting
Location
University of Alabama at Birmingham
Treatments Being Tested
Natalizumab/natalizumab-sztn, Alemtuzumab, Ocrelizumab, Rituximab/rituximab-arrx/rituximab-abbs/rituximab-pvvr, Cladribine, Ofatumumab, Ublituximab-xiiy, Ocrelizumab and hyaluronidase-ocsqGlatiramer acetate, Interferons (intramuscular, subcutaneous, pegylated) Teriflunomide, Fumarates (dimethyl, diroximel, monomethyl) Fingolimod, Siponimod, Ozanimod, Ponesimod Clinical Study to Investigate the Long-term Safety, Tolerability, and Efficacy of Ponesimod in Patients With Relapsing-remitting Multiple Sclerosis
PHASE2This study is an extension to the study AC-058B201 and will investigate the...
Location
Multiple Locations
Mass Balance, Pharmacokinetics, and Metabolism of 14C-labeled ACT-128800 Administered to Healthy Male Subjects
PHASE1The study was conducted to investigate the metabolism and mass balance of A...
Location
Swiss Pharma Contract
Study of the Electrocardiographic Effects of Ponesimod in Healthy Male and Female Subjects
PHASE1The aim of this study is to demonstrate that therapeutic and supratherapeut...
Location
Covance Clinical Research Unit (CRU)
Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ACT-128800 in Healthy Subjects
PHASE1This was a single-center, randomized, double-blind, placebo-controlled, up-...
Location
Quintiles Drug Research Unit at Guy's Hospital
Study to Evaluate the Pharmacokinetics, Tolerability, and Safety of ACT-128800 in Japanese and Caucasian Healthy Male and Female Subjects
PHASE1This is a study to evaluate the relative pharmacokinetic properties and the...
Location
Hawaii Clinical Research Center